Worth reading
44Recurring
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
30100
Shares (upon full exercise of the stock acquisition rights)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Issuance of stock acquisition rights for stock-based compensation stock options
Who receives how much
30,100 shares (301 stock acquisition rights, 100 shares per right, upon full exercise)
Eligible directors elected at the general meeting of shareholders held on 21 May 2025 (the number of eligible directors and the number of shares allotted to each person are 非開示)
The lower thin line represents the existing number of shares to which these shares will be added.
Accounting fair value on the allotment date (issued at no cost)
Terms of the stock acquisition rights
Exercise price
¥1 per share. Amendment provisions: Not disclosed
Exercise period
From 22 July 2026 to 21 July 2041
Number of Stock Acquisition Rights
301 stock acquisition rights issued in total; the number of outstanding unexercised rights is Not disclosed
Reason for acquisition without consideration
The Board of Directors resolves to acquire the rights without consideration in cases including a serious violation of laws or internal regulations, conviction resulting in imprisonment or a more severe penalty, appointment to a competing company without permission, the death of a successor to the rights, or an offer to waive all stock acquisition rights.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Conditions for lifting transfer restrictions
The holder must be a director or audit & supervisory board member at the time of exercise. However, the rights may be exercised within 5 years of the date of retirement.
Categories and Number of Persons Covered
Directors (number of people and number of shares allotted: not disclosed)
Intended allottee's holding policy
The holders of the stock acquisition rights and their successors may not transfer the rights or provide them as collateral.
Basis for determining the amount to be paid
Accounting fair value on the allotment date
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of stock acquisition rights for stock-based compensation stock options |
| Number of shares to be issued or disposed of | 30,100 shares (301 stock acquisition rights, 100 shares per right, upon full exercise) |
| Issue price and disposal price | Accounting fair value on the allotment date (issued at no cost) |
| Intended allottee | Eligible directors elected at the general meeting of shareholders held on 21 May 2025 (the number of eligible directors and the number of shares allotted to each person are Not disclosed) |
| Intended allottee's holding policy | The holders of the stock acquisition rights and their successors may not transfer the rights or provide them as collateral. |
| Basis for determining the amount to be paid | Accounting fair value on the allotment date |
| Exercise price | ¥1 per share. Amendment provisions: Not disclosed |
| Exercise period | From 22 July 2026 to 21 July 2041 |
| Number of Stock Acquisition Rights | 301 stock acquisition rights issued in total; the number of outstanding unexercised rights is Not disclosed |
| Conditions for lifting transfer restrictions | The holder must be a director or audit & supervisory board member at the time of exercise. However, the rights may be exercised within 5 years of the date of retirement. |
| Reason for acquisition without consideration | The Board of Directors resolves to acquire the rights without consideration in cases including a serious violation of laws or internal regulations, conviction resulting in imprisonment or a more severe penalty, appointment to a competing company without permission, the death of a successor to the rights, or an offer to waive all stock acquisition rights. |
| Categories and Number of Persons Covered | Directors (number of people and number of shares allotted: not disclosed) |
Items this document does not state (16)
Total issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateDilution RateTotal number of issued sharesTransfer restriction periodTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To strengthen the link between directors’ compensation and business performance and share value, share with shareholders not only the benefits of a rising share price but also the risk of a declining share price, and increase directors’ motivation and commitment to improving business performance and enhancing corporate value over the medium to long term.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.